CAS 916489-36-6

MS417

CAS: 916489-36-6

MS417 (GTPL7512) is an inhibitor of BET-specific BRD4(BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively), with weak

Formula: C₂₀H₁₉ClN₄O₂S

Purity: 99.87%

Color and Shape: Solid

Molecular weight: 414.91

Ref: TM-T16154

MS417

CAS: 916489-36-6

MS417

Purity: ≥98%

Molecular weight: 414.91g/mol

Ref: 54-BUP05461

MS417

Controlled Product

CAS: 916489-36-6

MS417 is a potent antagonist of the protein erythropoietin receptor and has shown to be effective in the treatment of tumor cells. The drug binds to the erythropoietin receptor, blocking the signal transduction pathway that leads to cell proliferation. MS417 has been shown to inhibit tumor growth in an experimental model and is currently being tested in clinical trials for cardiac dysfunction and treatment of HIV infection. It also inhibits the production of histones proteins that are involved in epigenetic regulation of gene expression.

Formula: C₂₀H₁₉ClN₄O₂S

Purity: Min. 95%

Molecular weight: 414.91 g/mol

Ref: 3D-RLB48936